Details for New Drug Application (NDA): 075493
✉ Email this page to a colleague
NDA 075493 describes VINCRISTINE SULFATE PFS, which is a drug marketed by Hospira and Teva Pharms Usa and is included in two NDAs. It is available from one supplier. Additional details are available on the VINCRISTINE SULFATE PFS profile page.
The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
Summary for 075493
| Tradename: | VINCRISTINE SULFATE PFS |
| Applicant: | Teva Pharms Usa |
| Ingredient: | vincristine sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 075493
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Sep 1, 1999 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
